These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1156 related items for PubMed ID: 15467034

  • 1. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S, Baiocchi RA, Vourganti S, Bhatt D, Blaser BW, Freud AG, Chou J, Chen CS, Xiao JJ, Parthun M, Chan KK, Eisenbeis CF, Ferketich AK, Grever MR, Chen CS, Caligiuri MA.
    J Natl Cancer Inst; 2004 Oct 06; 96(19):1447-57. PubMed ID: 15467034
    [Abstract] [Full Text] [Related]

  • 2. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
    Loomis R, Carbone R, Reiss M, Lacy J.
    Clin Cancer Res; 2003 May 06; 9(5):1931-9. PubMed ID: 12738752
    [Abstract] [Full Text] [Related]

  • 3. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
    Guinness ME, Kenney JL, Reiss M, Lacy J.
    Cancer Res; 2000 Oct 01; 60(19):5354-8. PubMed ID: 11034070
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC.
    Arch Virol; 2004 Feb 01; 149(2):289-302. PubMed ID: 14745596
    [Abstract] [Full Text] [Related]

  • 5. Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.
    Srimatkandada P, Loomis R, Carbone R, Srimatkandada S, Lacy J.
    Eur J Haematol; 2008 May 01; 80(5):407-18. PubMed ID: 18221384
    [Abstract] [Full Text] [Related]

  • 6. Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas.
    Katano H, Pesnicak L, Cohen JI.
    Proc Natl Acad Sci U S A; 2004 Apr 06; 101(14):4960-5. PubMed ID: 15041742
    [Abstract] [Full Text] [Related]

  • 7. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
    Röth A, Pfaff P, Lange W, Finke J.
    Cytokines Mol Ther; 1996 Mar 06; 2(1):21-8. PubMed ID: 9384686
    [Abstract] [Full Text] [Related]

  • 8. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H, Ishii C, Suehiro M, Iguchi A, Kuroda K, Shimizu K, Shimizu N, Imadome K, Yajima M, Fujiwara S.
    Virus Res; 2008 Feb 06; 131(2):170-9. PubMed ID: 17963943
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells.
    Zou P, Kawada J, Pesnicak L, Cohen JI.
    J Virol; 2007 Sep 06; 81(18):10029-36. PubMed ID: 17626072
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D.
    N Engl J Med; 1998 May 14; 338(20):1413-21. PubMed ID: 9580648
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B, Sabri S, Zelenika D, Deutsch E, Frascogna V, Klijanienko J, Vainchenker W, Joab I, Bourhis J.
    Oncogene; 2003 Apr 17; 22(15):2260-71. PubMed ID: 12700662
    [Abstract] [Full Text] [Related]

  • 18. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
    Lifang Y, Min T, Midan A, Ya C.
    J Exp Clin Cancer Res; 2008 Sep 23; 27(1):42. PubMed ID: 18811956
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Szekely L, Pokrovskaja K, Klein G.
    Cell Growth Differ; 1997 May 23; 8(5):599-609. PubMed ID: 9149911
    [Abstract] [Full Text] [Related]

  • 20. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Westphal EM, Blackstock W, Feng W, Israel B, Kenney SC.
    Cancer Res; 2000 Oct 15; 60(20):5781-8. PubMed ID: 11059774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.